Art. 1 Commission Regulation (EC) No 847/2000 of 27 April 2000 laying down the provisions for i…

Purpose

In forcesince 19 Jun 2018

This Regulation lays down factors to be considered when implementing Article 3 of Regulation (EC) No 141/2000 on orphan medicinal products and establishes definitions of ‘similar medicinal product’ and ‘clinical superiority’ for the purposes of implementing Article 8 of the abovementioned Regulation. It is intended to assist potential sponsors, the Committee for Orphan Medicinal Products, and competent authorities in the interpretation of Regulation (EC) No 141/2000.